TMCnet News
SetPoint Medical Appoints Anna Gawlicka as VP of Clinical AffairsVALENCIA, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage company developing therapy for chronic autoimmune diseases, today announced the appointment of Anna Gawlicka, PhD, as Vice President of Clinical Affairs. “Anna has a proven track record of success in clinical affairs with direct experience in clinical trial planning and execution that will be invaluable as we look to begin the U.S. pivotal trial of our bioelectronic medicine platform for the treatment of rheumatoid arthritis,” commented Murthy Simhambhatla, PhD, President and Chief Executive Officer of SetPoint Medical. Dr. Gawlicka has more than 20 years of experience in directing clinical research, product development, and commercialization efforts. Most recently, she was Senior Director of Clinical & Medical Affairs at Intersect ENT. Prior to Intersect ENT, she held the position of Senior Director of Clinical Affairs at Vibrynt, Inc. and has held various clinical affairs roles at USGI Medical, EndoGastric Solutions, and AIBMR Life Sciences. Dr. Gawlicka obtained her PhD in Nutrition from Laval University and her MBA in Health Care from University of CaliforniaIrvine. Additionally, she received a certificate in Clinical Trials from University of Washington. Dr. Gawlicka added, “I am excited to join SetPoint Medical at this opportune time to advance its bioelectronic medicine program as a potential alternative for the treatment of chronic, inflammation-mediated autoimmune diseases.” About SetPoint Medical Contacts Media Contact: Investor Relation Contact: |